Conflict of interests: Dr. Bi, Mr. Sun, and Dr. Gelernter have no disclosures. Dr. Kranzler has been a consultant or advisory board member for Alkermes, Lilly, Lundbeck, Pfizer, and Roche. He is also a member of the American Society of Clinical Psychopharmacology's Alcohol Clinical Trials Initiative, which is supported by Lilly, Lundbeck, Abbott, and Pfizer.
Comparing the utility of homogeneous subtypes of cocaine use and related behaviors with DSM-IV cocaine dependence as traits for genetic association analysis
Article first published online: 11 DEC 2013
© 2013 Wiley Periodicals, Inc.
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Volume 165, Issue 2, pages 148–156, March 2014
How to Cite
2013. Comparing the Utility of Homogeneous Subtypes of Cocaine Use and Related Behaviors With DSM-IV Cocaine Dependence as Traits for Genetic Association Analysis. Am J Med Genet Part B 165B:148–156., , , .
- Issue published online: 6 FEB 2014
- Article first published online: 11 DEC 2013
- Manuscript Accepted: 20 NOV 2013
- Manuscript Received: 2 MAY 2013
- NIH. Grant Numbers: DA12849, DA12690, AA03510, AA11330, AA13736
- VISN 1 and VISN 4 Mental Illness Research, Education, and Clinical Centers (MIRECCs)
This article has been cited by:
- 2Genome-Wide Association Studies of Substance Use: Considerations Regarding Populations and Phenotypes, Biological Psychiatry, 2015, 77, 5, 423, ,